Intermountain Medical Center
Salt Lake City, Utah, 84157, United States
NCT Number: NCT03015584
This study will use systems biology techniques, especially RNA-seq, to understand cognitive impairment after sepsis requiring an intensive care unit (ICU) admission.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Salt Lake City, Utah, 84157, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A. SEPSIS:
PRESENCE OF
OR
B. SEPTIC SHOCK:
AFTER INTRAVENOUS INFUSION OF 20ML/KG CRYSTALLOID OR EQUIVALENT, PRESENCE OF
Enrollment within 48 hours of ICU admission.
Must live within 200 miles of Intermountain Medical Center
Subject is at least 18 years of age or older
Must speak English
Exclusion criteria
Time frame: 6 months
Measures executive function. 6-month Hayling Sentence Completion test is the prespecified primary outcome.
Time frame: 3 months
Time frame: 6 months
Time frame: 3 months
Time frame: 6 months
Time frame: 3 months
Time frame: 6 months
Time frame: 3 months
Time frame: 6 months
Time frame: 3 months
Time frame: 6 months
Time frame: 3 months
Time frame: 6 months
Time frame: 3 months
Time frame: 6 months
Time frame: 3 months
Time frame: 6 months
Time frame: 3 months
Time frame: 6 months
Time frame: 3 months
Time frame: 6 months
Time frame: 3 months
Time frame: 6 months
Time frame: 3 months
Time frame: 6 months
Time frame: 3 months
Time frame: 90 days
Intermountain Health Care, Inc.
Other
Systems Biology Approach to Cognitive Impairment After SepsiS (CASS)
Acronym: CASS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02914756
Cognition Disorders, Cognitive Dysfunction
Stockholm, Sweden
View Trial DetailsNCT03031275
Acute Respiratory Distress Syndrome, Cognition Disorders
Stockholm, Sweden
View Trial DetailsNCT03115840
Behavior, Cognition Disorders
Columbus, Ohio, United States
View Trial DetailsNCT05448534
Cognition Disorders, Cognitive Dysfunction
São Luís, Maranhão, Brazil
View Trial Details